Promising cancer immunotherapeutic agent

被引：0
|
作者：
Li, B.
VanRoey, M.
Triebel, F.
Jooss, K.
机构：
来源：
EXPERT REVIEW OF VACCINES | 2008年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：710 / 710
页数：1
相关论文
共 50 条
  • [1] Promising cancer immunotherapeutic agent unveiled
    不详
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1204 - 1204
  • [2] Milatuzumab - a promising new immunotherapeutic agent
    Berkova, Zuzana
    Tao, Rong-Hua
    Samaniego, Felipe
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (01) : 141 - 149
  • [3] Decitabine: a promising epi-immunotherapeutic agent in solid tumors
    Li, Xiang
    Mei, Qian
    Nie, Jing
    Fu, Xiaobing
    Han, Weidong
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (03) : 363 - 375
  • [4] LTX-315 - a promising novel antitumor peptide and immunotherapeutic agent
    Zweytick, Dagmar
    CELL STRESS, 2019, 3 (11) : 328 - 329
  • [5] Bispecific Antibodies (bsAbs): Promising Immunotherapeutic Agents for Cancer Therapy
    Acheampong, Desmond O.
    Adokoh, Christian K.
    Ampomah, Paulina
    Agyirifo, Daniel S.
    Dadzie, Isaac
    Ackah, Francis A.
    Asiamah, Ernest A.
    PROTEIN AND PEPTIDE LETTERS, 2017, 24 (05): : 456 - 465
  • [6] T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
    Zhou, Qi
    Tao, Xufeng
    Xia, Shilin
    Guo, Fangyue
    Pan, Chen
    Xiang, Hong
    Shang, Dong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment
    Zhu, Ziwen
    Parikh, Pooja
    Zhao, Hongyun
    Givens, Nathan T.
    Beck, Damien B.
    Willson, Conner M.
    Bai, Qian
    Wakefield, Mark R.
    Fang, Yujiang
    CANCER LETTERS, 2021, 518 : 94 - 101
  • [8] Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy
    Zhang, Si-Yu
    Song, Xin-Yu
    Li, Yang
    Ye, Lin-Lin
    Zhou, Qiong
    Yang, Wei-Bing
    PHARMACOLOGICAL RESEARCH, 2020, 161
  • [9] Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment
    Yang, Fei-Fei
    Hu, Ting
    Liu, Jian-Quan
    Yu, Xiao-Qian
    Ma, Li-Ying
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 245
  • [10] Cinobufagin: a promising therapeutic agent for cancer
    Dai, Chun-Lan
    Zhang, Run-jing
    An, Pei
    Deng, Yi-Qing
    Rahman, Khalid
    Zhang, Hong
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2023, 75 (09) : 1141 - 1153
12345